Pharmacological Inhibition of Nicotinamide Phosphoribosyltransferase/Visfatin Enzymatic Activity Identifies a New Inflammatory Pathway Linked to NAD

Nicotinamide phosphoribosyltransferase (NAMPT), also known as visfatin, is the rate-limiting enzyme in the salvage pathway of NAD biosynthesis from nicotinamide. Since its expression is upregulated during inflammation, NAMPT represents a novel clinical biomarker in acute lung injury, rheumatoid arthritis, and Crohn's disease. However, its role in disease progression remains unknown. We report here that NAMPT is a key player in inflammatory arthritis. Increased expression of NAMPT was confirmed in mice with collagen-induced arthritis, both in serum and in the arthritic paw. Importantly, a specific competitive inhibitor of NAMPT effectively reduced arthritis severity with comparable activity to etanercept, and decreased pro-inflammatory cytokine secretion in affected joints. Moreover, NAMPT inhibition reduced intracellular NAD concentration in inflammatory cells and circulating TNFα levels during endotoxemia in mice. In vitro pharmacological inhibition of NAMPT reduced the intracellular concentration of NAD and pro-inflammatory cytokine secretion by inflammatory cells. Thus, NAMPT links NAD metabolism to inflammatory cytokine secretion by leukocytes, and its inhibition might therefore have therapeutic efficacy in immune-mediated inflammatory disorders.

[1]  J. Milbrandt,et al.  Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. , 2007, Cell metabolism.

[2]  R. Nazar,et al.  Borrowing from Biology , 2007, Science.

[3]  R. Gay,et al.  Pre-B cell colony-enhancing factor/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities. , 2007, Arthritis and rheumatism.

[4]  M. Matsuda,et al.  Visfatin is released from 3T3-L1 adipocytes via a non-classical pathway. , 2007, Biochemical and biophysical research communications.

[5]  Kyu-Won Kim,et al.  Visfatin promotes angiogenesis by activation of extracellular signal-regulated kinase 1/2. , 2007, Biochemical and biophysical research communications.

[6]  David Sinclair,et al.  Sirtuins in mammals: insights into their biological function. , 2007, The Biochemical journal.

[7]  Yeon-Ah Lee,et al.  Synovial proliferation differentially affects hypoxia in the joint cavities of rheumatoid arthritis and osteoarthritis patients , 2007, Clinical Rheumatology.

[8]  S. Imai,et al.  The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals , 2007, Current opinion in gastroenterology.

[9]  H. Tilg,et al.  Visfatin , an Adipocytokine with Proinflammatory and Immunomodulating Properties 1 , 2007 .

[10]  L. Guarente.  Sirtuins as potential targets for metabolic syndrome , 2006, Nature.

[11]  M. Matsuda,et al.  Visfatin in adipocytes is upregulated by hypoxia through HIF1alpha-dependent mechanism. , 2006, Biochemical and biophysical research communications.

[12]  D. Veale,et al.  Inhibition of angiogenic pathways in rheumatoid arthritis: potential for therapeutic targeting. , 2006, Best practice & research. Clinical rheumatology.

[13]  S. Eom,et al.  Crystal structure of visfatin/pre-B cell colony-enhancing factor 1/nicotinamide phosphoribosyltransferase, free and in complex with the anti-cancer agent FK-866. , 2006, Journal of molecular biology.

[14]  M. Hasmann,et al.  Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents. , 2006, European journal of medical research.

[15]  M. Yoo,et al.  Hypoxic induction of human visfatin gene is directly mediated by hypoxia‐inducible factor‐1 , 2006, FEBS letters.

[16]  C. Fielding,et al.  Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis. , 2006, Arthritis and rheumatism.

[17]  P. Villiger,et al.  Inhibition of IL-1, IL-6, and TNF-α in immune-mediated inflammatory diseases , 2006, Springer Seminars in Immunopathology.

[18]  M. Zaidi,et al.  TNF regulates cellular NAD+ metabolism in primary macrophages. , 2006, Biochemical and biophysical research communications.

[19]  J. Gómez-Reino,et al.  Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis , 2006, Annals of the rheumatic diseases.

[20]  P. Villiger,et al.  Inhibition of IL-1, IL-6, and TNF-alpha in immune-mediated inflammatory diseases. , 2006, Springer seminars in immunopathology.

[21]  J. Khan,et al.  Molecular basis for the inhibition of human NMPRTase, a novel target for anticancer agents , 2006, Nature Structural &Molecular Biology.

[22]  M. Matsuda,et al.  Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. , 2005, Science.

[23]  Peter C Taylor,et al.  Hypoxia and angiogenesis in rheumatoid arthritis , 2005, Current opinion in rheumatology.

[24]  J. Koutcher,et al.  Metabolic Signatures Associated with a NAD Synthesis Inhibitor–Induced Tumor Apoptosis Identified by 1H-Decoupled-31P Magnetic Resonance Spectroscopy , 2005, Clinical Cancer Research.

[25]  T. Standiford,et al.  Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury. , 2005, American journal of respiratory and critical care medicine.

[26]  G. Fantuzzi,et al.  The Histone Deacetylase Inhibitor ITF2357 Reduces Production of Pro-Inflammatory Cytokines In Vitro and Systemic Inflammation In Vivo , 2005, Molecular medicine.

[27]  S. Imai,et al.  The NAD Biosynthesis Pathway Mediated by Nicotinamide Phosphoribosyltransferase Regulates Sir2 Activity in Mammalian Cells* , 2004, Journal of Biological Chemistry.

[28]  J. Marshall,et al.  Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. , 2004, The Journal of clinical investigation.

[29]  R. Pero,et al.  Newly discovered anti-inflammatory properties of the benzamides and nicotinamides , 1999, Molecular and Cellular Biochemistry.

[30]  B. Rattel,et al.  Antiangiogenic potency of FK866/K22.175, a new inhibitor of intracellular NAD biosynthesis, in murine renal cell carcinoma. , 2003, Anticancer research.

[31]  Max Hasmann,et al.  FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. , 2003, Cancer research.

[32]  R. Khokha,et al.  Metalloproteinases, inflammation, and rheumatoid arthritis , 2003, Annals of the rheumatic diseases.

[33]  F. Andris,et al.  Reconstructing eukaryotic NAD metabolism. , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.

[34]  D. Gigot,et al.  Pre‐B‐cell colony‐enhancing factor, whose expression is up‐regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis , 2002, European journal of immunology.

[35]  M. Hottiger,et al.  The functional role of poly(ADP-ribose)polymerase 1 as novel coactivator of NF-κB in inflammatory disorders , 2002, Cellular and Molecular Life Sciences CMLS.

[36]  M. Feldmann,et al.  Cytokines and anti-cytokine biologicals in autoimmunity: present and future. , 2002, Cytokine & growth factor reviews.

[37]  B. Rattel,et al.  WK175, a novel antitumor agent, decreases the intracellular nicotinamide adenine dinucleotide concentration and induces the apoptotic cascade in human leukemia cells. , 2002, Cancer research.

[38]  E. Lander,et al.  Human macrophage activation programs induced by bacterial pathogens , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Joshua M. Korn,et al.  The plasticity of dendritic cell responses to pathogens and their components. , 2001, Science.

[40]  S. Ognjanovic,et al.  Genomic organization of the gene coding for human pre-B-cell colony enhancing factor and expression in human fetal membranes. , 2001, Journal of molecular endocrinology.

[41]  M. Ziegler.  New functions of a long-known molecule. Emerging roles of NAD in cellular signaling. , 2000, European journal of biochemistry.

[42]  Retraction Kiehntopf,et al.  Retraction , 1997, Concurr. Comput. Pract. Exp..

[43]  S. Bavari,et al.  Protective effects of niacinamide in staphylococcal enterotoxin-B-induced toxicity. , 1996, Toxicology.

[44]  T. C. Wagner,et al.  Single extraction method for the spectrophotometric quantification of oxidized and reduced pyridine nucleotides in erythrocytes. , 1994, Analytical biochemistry.

[45]  I McNiece,et al.  Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor , 1994, Molecular and cellular biology.

[46]  E. Brahn,et al.  Angiogenesis inhibition suppresses collagen arthritis , 1992, The Journal of experimental medicine.

[47]  J. Kremer,et al.  Methotrexate for Rheumatoid Arthritis , 1994 .